The Trump administration’s halting of NIH study section submissions to the Federal Register effectively shut down the NIH’s extramural research program, likely violating a court order. This action prevents the peer review of grant proposals, delaying billions of dollars in crucial medical research funding. The administration’s actions, which even some within the NIH struggle to comprehend, have caused widespread confusion and significant delays, potentially jeopardizing ongoing research projects. This blatant disregard for judicial mandates leaves open the possibility of further legal repercussions for those involved.
Read More
The Trump administration, aided by Elon Musk, is illegally slashing billions from the NIH and NSF, crippling scientific research across the nation. This attack, framed as targeting elite universities, severely impacts public universities and scientific research nationwide. Musk’s actions are particularly egregious given his reliance on government-funded research throughout his career, from the internet to electric vehicle technology. The cuts will irreparably harm research into critical areas like cancer and Alzheimer’s, ultimately impacting the health and well-being of American citizens.
Read More
The Trump administration’s National Institutes of Health (NIH) implemented a $4 billion annual reduction in indirect medical research funding, limiting associated costs to 15% of awarded grants. This decision, justified as reallocating funds towards direct research, is projected to significantly impact universities and research institutions. Critics, including Democrats and research organizations, warn of potentially catastrophic consequences for vital medical research and innovation, with potential harm to patients. Supporters, conversely, praise the move as efficient government spending.
Read More
The Trump administration abruptly halted NIH grant review panels and imposed a broad communication blackout across HHS, impacting agencies like the NIH, FDA, and CDC. This pause affects billions of dollars in research funding, delaying crucial studies on diverse topics ranging from cancer to the opioid crisis. The disruption also includes the suspension of advisory council meetings, further hindering the approval of new research grants. Researchers express deep concern about the impact on scientific progress, the loss of valuable expertise, and the potential negative consequences for patient care. The long-term effects of this freeze remain uncertain, but significant delays and a chilling effect on scientific endeavors are anticipated.
Read More
John Q. Hosedrinker